• EN/ES

    Orthopedics

    WebHealthNetwork : 2,378,479


  • Benefits & Savings

  • : Neoplasms, Adipose Tissue

Neoplasms, Adipose Tissue - 5 Studies Found

Completed : Sitagliptin and Brown Adipose Tissue
: Neoplasms, Adipose Tissue
: 2014-11-17
:
  • Drug: Sitagliptin Each subject

Terminated : Nelfinavir Mesylate in Treating Patients With Recurrent, Metastatic, or Unresectable Liposarcoma
:
  • Adult Liposarcoma
  • Recurrent Adult Soft Tissue Sarcoma
  • Stag
    : 2005-10-05
    :
    • Drug: nelfinavir mesylate Give

Completed : Rosiglitazone in Treating Patients With Liposarcoma
: Sarcoma
: 2000-01-21
: Drug: rosiglitazone maleate Other Name: Rosiglitazone
Completed : Troglitazone in Treating Patients With Liposarcoma
: Sarcoma
: 1999-11-01
: Drug: troglitazone Other Name: Rezulin
Completed : Retrospective Evaluation of Liposarcoma
: Survival , Tumor
: 2017-01-22
: Procedure: Patients with Liposarcoma Evaluation of Liposarcoma treated in a single center
Orthopedics Health
Orthopedics Health WebHealth Network Media
  • WebHealthNetwork
  • DiabetesHealthMatters
  • HeartandStrokeHealth
  • WomensHealthCareCommunity
  • AsthmaHealthCenter
  • CancerHealthCenter
  • MentalHealthHelpCenter
  • Skincarehealthcenter
  • DigestiveTractHealth
  • VaccineHealthCenter
  • PainHealthCenter
  • FightingAddictionCenter
  • ObesityHealthMatters
  • SeniorHealthcareMatters
  • BrainAndNerveCenter
  • PediatricsHealthCenter
  • RareDiseasesHealthCenter
  • Wealth Mason
  • Home Owners Circle
  • EasyInsuranceFinder
  • EduJumpStart
  • SaleSpider
  • ScoopCafe
  • SaleSpiderMedia
  • Viewpoint.World
  • TravelerBooked
  • TechNewsBytes
  • Contact Us
  • Advertising Privacy Policy

This site uses cookies for analytics and advertising. No personal information is collected.

© Orthopedics Health .

We use cookies to enhance your experience, analyze anonymized traffic, and deliver personalized content and ads. No personal information is collected. By using our website, you consent to our use of cookies and agree to our data practices as described in our Privacy Policy. To Reject, please change your browser settings.